UNITED STATES ~~SECURITIES AND EXCHANGE COMMISSION~~

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934

For the month of December 2018

Commission File Number: 001-36403

IKANG HEALTHCARE GROUP, INC.

(Exact name of registrant as specified in its charter)

B-6F, Shimao Tower

92A Jianguo Road

Chaoyang District, Beijing 100022

People’s Republic of China
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IKANG HEALTHCARE GROUP, INC.

	By:	/s/ YANG CHEN
	Name:	Yang Chen
	Title:	Chief Financial Officer

Date: December 1421, 2018

Exhibit Index

Exhibit 99.1		Amendment No. 3 to the Agreement and Plan of Merger, dated as of December 14, 2018, by and among IK Healthcare Investment Limited, IK Healthcare Merger Limited and iKang Healthcare Group, Inc.
Exhibit 99.2		Press Release: iKang Enters into Amendment No. 3 to Merger Agreement for Going Private Transaction

Exhibit 99.1 — iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018

Filing Compare · iKang Healthcare Group, Inc.